feed,title,long_url,short_url
Benzinga,ASLAN Pharma Starts Eblasakimab Program In Dupixent Treated Dermatitis Patients,https://benzinga.com/general/biotech/22/09/28866270/aslan-pharma-starts-eblasakimab-program-in-dupixent-treated-dermatitis-patients,https://bit.ly/3xrsCsv
